title: Rifampicin-induced pure red cell aplasia.
authors.affiliation: Hôpital Saint Louis, Paris, France.
authors.forename: X
authors.initials: X
authors.lastname: Mariette
authors.forename: M T
authors.initials: MT
authors.lastname: Mitjavila
authors.forename: J P
authors.initials: JP
authors.lastname: Moulinie
authors.forename: A
authors.initials: A
authors.lastname: Bussel
authors.forename: J C
authors.initials: JC
authors.lastname: Brouet
authors.forename: W
authors.initials: W
authors.lastname: Vainchenker
authors.forename: J P
authors.initials: JP
authors.lastname: Fermand
mesh_terms: D000328:Adult; D004912:Erythrocytes / Q000187:drug effects; D015672:Erythroid Precursor Cells / Q000187:drug effects; D005260:Female; D006801:Humans; D015366:Pefloxacin / Q000009:adverse effects; D012010:Red-Cell Aplasia, Pure / Q000097:blood / Q000139:chemically induced*; D012293:Rifampin / Q000009:adverse effects*
chemical_list: D015366:Pefloxacin; D012293:Rifampin